Published in Health Psychol on January 01, 1991
Gender-related Differences in Food Craving and Obesity. Yale J Biol Med (2016) 0.83
Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A (1989) 4.01
The function of ubiquinone in Escherichia coli. Biochem J (1970) 3.91
Expression and amplification of cyclin genes in human breast cancer. Oncogene (1993) 3.79
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med (2001) 2.60
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci U S A (1995) 2.57
Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol (2000) 2.33
Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol (1998) 2.30
Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol (1980) 2.15
Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer (1998) 2.06
Ionization and phase behavior of fatty acids in water: application of the Gibbs phase rule. Biochemistry (1988) 1.94
The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem (1992) 1.85
Biochemical and genetic studies on ubiquinone biosynthesis in Escherichia coli K-12:4-hydroxybenzoate octaprenyltransferase. J Bacteriol (1972) 1.81
pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. Proc Natl Acad Sci U S A (1992) 1.77
Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations. Am J Clin Nutr (1970) 1.71
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res (2001) 1.66
The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol (2000) 1.66
Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol (1993) 1.65
Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. J Immunol (1988) 1.65
Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum (2001) 1.61
Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Immunology (1989) 1.60
Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem (1991) 1.55
Pregnancy rates after embryo transfer depend on the provider at embryo transfer. Fertil Steril (2000) 1.53
Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers. Biochemistry (1993) 1.53
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J (1993) 1.49
Hapten-specific tolerance: unresponsiveness in the T cell-depleted population. Eur J Immunol (1973) 1.47
Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis Cartilage (2008) 1.45
Fatty acid flip-flop in phospholipid bilayers is extremely fast. Biochemistry (1995) 1.43
Priming of the respiratory burst of bone marrow-derived macrophages is associated with an increase in protein kinase C content. J Immunol (1992) 1.42
Ubisemiquinone in membranes from Escherichia coli. Biochem J (1970) 1.40
Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice. Ann Rheum Dis (1997) 1.31
Priming the macrophage respiratory burst with IL-4: enhancement with TNF-alpha but inhibition by IFN-gamma. Immunology (1990) 1.31
Dissociation of long and very long chain fatty acids from phospholipid bilayers. Biochemistry (1996) 1.29
Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol (1998) 1.27
Augmentation of glucocorticoid action on human monocytes by interleukin-4. Lymphokine Res (1990) 1.27
Profound increase in viscosity and aggregation of pig gastric mucin at low pH. Am J Physiol (1991) 1.27
Transbilayer movement of bile acids in model membranes. Biochemistry (1987) 1.24
Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. Proc Natl Acad Sci U S A (2005) 1.24
Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology (2003) 1.22
Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants. J Immunol (1981) 1.21
Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin Exp Immunol (2005) 1.20
Purification of two forms of colony-stimulating factor from mouse L-cell-conditioned medium. J Biol Chem (1985) 1.19
Phase behavior and bilayer properties of fatty acids: hydrated 1:1 acid-soaps. Biochemistry (1986) 1.18
Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. I. The filling of individual fatty acid binding sites. J Biol Chem (1987) 1.18
Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest (1995) 1.18
Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J Biol Chem (1998) 1.16
Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J (1986) 1.15
Solubilization and localization of triolein in phosphatidylcholine bilayers: a 13C NMR study. Proc Natl Acad Sci U S A (1981) 1.15
Human monocytes can produce tissue-type plasminogen activator. J Exp Med (1989) 1.14
Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum (1987) 1.14
Interactions of the carboxyl group of oleic acid with bovine serum albumin: a 13C NMR study. J Biol Chem (1983) 1.14
Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. II. Electrostatic interactions in individual fatty acid binding sites. J Biol Chem (1987) 1.13
Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology (2001) 1.13
Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood (1998) 1.13
Transfer of oleic acid between albumin and phospholipid vesicles. Proc Natl Acad Sci U S A (1986) 1.11
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. Psychosom Med (1992) 1.10
Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol (1983) 1.10
CSF-1 stimulates Na+K+-ATPase mediated 86Rb+ uptake in mouse bone marrow-derived macrophages. Biochem Biophys Res Commun (1985) 1.10
Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase. J Biol Chem (2001) 1.10
Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes. Am J Physiol Endocrinol Metab (2001) 1.09
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference? Psychosom Med (1992) 1.09
Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther (2006) 1.07
Flexibility is a likely determinant of binding specificity in the case of ileal lipid binding protein. Structure (1996) 1.07
Tumor-promoting phorbol esters stimulate hematopoietic colony formation in vitro. Science (1980) 1.05
Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatol (1988) 1.04
In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol (2001) 1.03
Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid. Arthritis Rheum (1988) 1.03
13C MAS NMR studies of crystalline cholesterol and lipid mixtures modeling atherosclerotic plaques. Biophys J (1996) 1.03
Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin Exp Immunol (2000) 1.02
Impairment of dentato-thalamo-cortical pathway in autistic men: language activation data from positron emission tomography. Neurosci Lett (1998) 1.02
Interactions of oleic acid with liver fatty acid binding protein: a carbon-13 NMR study. Biochemistry (1988) 1.01
A comparative analysis of ejaculate and hormonal characteristics of the captive male cheetah, tiger, leopard, and puma. Biol Reprod (1988) 1.01
Inhibition of the signaling pathways for macrophage proliferation by cyclic AMP. Lack of effect on early responses to colony stimulating factor-1. J Biol Chem (1990) 1.00
The generation of highly enriched osteoclast-lineage cell populations. Bone (2002) 1.00
Tissue-type plasminogen activator deficiency exacerbates arthritis. J Immunol (2001) 1.00
A multinuclear solid-state NMR study of phospholipid-cholesterol interactions. Dipalmitoylphosphatidylcholine-cholesterol binary system. Biochemistry (1995) 1.00
Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem (1992) 1.00
Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum (1990) 1.00
Interactions of myristic acid with bovine serum albumin: a 13C NMR study. Proc Natl Acad Sci U S A (1984) 0.99
Beauvericin and divalent cations: crystal structure of the barium complex. Biochem Biophys Res Commun (1975) 0.99
Regulation of human monocyte DNA synthesis by colony-stimulating factors, cytokines, and cyclic adenosine monophosphate. Blood (1992) 0.99
Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem (2001) 0.98
Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1. J Immunol (1991) 0.98
Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor alpha. Biochim Biophys Acta (1993) 0.98
Solution structure of human intestinal fatty acid binding protein: implications for ligand entry and exit. J Biomol NMR (1997) 0.97
Structure of human beta 1 beta 1 alcohol dehydrogenase: catalytic effects of non-active-site substitutions. Proc Natl Acad Sci U S A (1991) 0.97
Macrophage stimulation and the inflammatory response to asbestos. Environ Health Perspect (1980) 0.97
Contrasting effects of interferon-gamma and interleukin-4 on the interleukin-6 activity of stimulated human monocytes. Immunology (1990) 0.97
Solubilization of triolein and cholesteryl oleate in egg phosphatidylcholine vesicles. J Biol Chem (1983) 0.97
Interactions of lyso 1-palmitoylphosphatidylcholine with phospholipids: a 13C and 31P NMR study. Biochemistry (1995) 0.97
Phorbol ester-stimulated superoxide production by murine bone marrow-derived macrophages requires preexposure to cytokines. J Immunol (1989) 0.96
Rotational and segmental motions in the lipids of human plasma lipoproteins. J Biol Chem (1974) 0.96
Performance of breast self-examination by women at high risk for breast cancer. Women Health (1987) 0.96
Activation of human monocytes by granulocyte-macrophage colony-stimulating factor: increased urokinase-type plasminogen activator activity. Blood (1991) 0.96
Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for STAT1 activation in response to CSF-1. Oncogene (1996) 0.96